Expert Highlights Breakthroughs and Next Steps in RCC Paradigm
Published: Thursday, Apr 02, 2020
Matthew T. Campbell, MD, MS
Single-agent immunotherapy and combination regimens have revolutionized the treatment paradigm for patients with renal cell carcinoma (RCC), explained Matthew T. Campbell, MD, MS.
... to read the full story